# Fusemachines Inc.: financial statements, quarterly

FUSE · Nasdaq · CIK 2033383 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fuse.md) · [Financials](/companies/fuse/financials.md) · [Filings](/companies/fuse/filings.md) · [Insiders](/companies/fuse/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fuse/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [2.0](/filings/0001493152-26-023864.md) | [2.0](/filings/0001493152-26-036603.md) | not reported | not reported | [1.9](/filings/0001493152-26-023864.md) | [1.8](/filings/0001493152-26-036603.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | [0.9](/filings/0001493152-26-023864.md) | [0.8](/filings/0001493152-26-036603.md) | not reported | not reported | [0.9](/filings/0001493152-26-023864.md) | [0.8](/filings/0001493152-26-036603.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | [1.1](/filings/0001493152-26-023864.md) | [1.2](/filings/0001493152-26-036603.md) | not reported | not reported | [0.9](/filings/0001493152-26-023864.md) | [1.0](/filings/0001493152-26-036603.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | [0.2](/filings/0001493152-26-023864.md) | [0.2](/filings/0001493152-26-036603.md) | not reported | not reported | [0.3](/filings/0001493152-26-023864.md) | [0.3](/filings/0001493152-26-036603.md) |
| Selling, general and administrative | $m | not reported | not reported | [0.0](/filings/0001493152-25-025230.md) | not reported | not reported | not reported | [0.0](/filings/0001493152-25-025230.md) | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [(0.6)](/filings/0001493152-25-025230.md) | [(6.8) d](/filings/0001493152-26-013285.md) | [(1.3)](/filings/0001493152-26-023864.md) | [(0.9)](/filings/0001493152-26-036603.md) | [(1.1)](/filings/0001493152-25-025230.md) | [(4.0) d](/filings/0001493152-26-013285.md) | [(3.0)](/filings/0001493152-26-023864.md) | [(2.7)](/filings/0001493152-26-036603.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [17.6](/filings/0001493152-25-025230.md) | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-023864.md) | [0.0 d](/filings/0001493152-26-036603.md) |
| Net income | $m | [0.1](/filings/0001493152-25-025230.md) | [0.4](/filings/0001493152-25-025230.md) | [(0.1)](/filings/0001493152-25-025230.md) | [(15.8) d](/filings/0001493152-26-013285.md) | [(2.1)](/filings/0001493152-25-025230.md) | [(0.2)](/filings/0001493152-25-025230.md) | [(19.8)](/filings/0001493152-25-025230.md) | [21.2 d](/filings/0001493152-26-013285.md) | [(0.9)](/filings/0001493152-26-023864.md) | [(2.8)](/filings/0001493152-26-036603.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.03)](/filings/0001493152-26-023864.md) | [(0.52)](/filings/0001493152-26-036603.md) | not reported | not reported | [(0.03)](/filings/0001493152-26-023864.md) | [(0.10)](/filings/0001493152-26-036603.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.03)](/filings/0001493152-26-023864.md) | [(0.52)](/filings/0001493152-26-036603.md) | not reported | not reported | [(0.03)](/filings/0001493152-26-023864.md) | [(0.10)](/filings/0001493152-26-036603.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | period not labelled (2025-10-22) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.5](/filings/0001493152-26-013285.md) | not reported | not reported | [0.0](/filings/0001493152-25-025230.md) | [9.4](/filings/0001493152-26-013285.md) | [4.2](/filings/0001493152-26-036603.md) | [1.8](/filings/0001493152-26-023864.md) | [0.4](/filings/0001493152-26-036603.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [4.1](/filings/0001493152-26-013285.md) | not reported | not reported | [12.4](/filings/0001493152-25-025230.md) | not reported | [6.3](/filings/0001493152-26-036603.md) | [3.7](/filings/0001493152-26-023864.md) | [2.0](/filings/0001493152-26-036603.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [5.5](/filings/0001493152-26-013285.md) | not reported | not reported | [12.4](/filings/0001493152-25-025230.md) | not reported | [7.5](/filings/0001493152-26-036603.md) | [4.9](/filings/0001493152-26-023864.md) | [3.2](/filings/0001493152-26-036603.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [20.3](/filings/0001493152-26-013285.md) | not reported | not reported | [43.9](/filings/0001493152-25-025230.md) | not reported | [20.0](/filings/0001493152-26-036603.md) | [18.1](/filings/0001493152-26-023864.md) | [18.7](/filings/0001493152-26-036603.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [29.9](/filings/0001493152-26-013285.md) | not reported | not reported | [43.9](/filings/0001493152-25-025230.md) | not reported | [22.1](/filings/0001493152-26-036603.md) | [20.0](/filings/0001493152-26-023864.md) | [20.5](/filings/0001493152-26-036603.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [6.7](/filings/0001493152-26-013285.md) | not reported | not reported | not reported | not reported | [0.3](/filings/0001493152-26-036603.md) | [0.3](/filings/0001493152-26-023864.md) | [0.3](/filings/0001493152-26-036603.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [9.9](/filings/0001493152-26-013285.md) | not reported | not reported | not reported | not reported | [0.3](/filings/0001493152-26-036603.md) | [0.3](/filings/0001493152-26-023864.md) | [0.3](/filings/0001493152-26-036603.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.3](/filings/0001493152-26-036603.md) | [0.2](/filings/0001493152-26-023864.md) | [0.1](/filings/0001493152-26-036603.md) |
| Shareholders' equity | $m | [(8.5)](/filings/0001493152-26-013285.md) | [(9.0)](/filings/0001493152-25-025230.md) | [(9.5)](/filings/0001493152-25-025230.md) | [(10.2)](/filings/0001493152-25-025230.md) | [(24.3)](/filings/0001493152-26-036603.md) | [(24.1)](/filings/0001493152-26-036603.md) | [(27.8)](/filings/0001493152-26-036603.md) | [(42.6)](/filings/0001493152-25-025230.md) | not reported | [(14.6)](/filings/0001493152-26-036603.md) | [(15.0)](/filings/0001493152-26-036603.md) | [(17.4)](/filings/0001493152-26-036603.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.6) d](/filings/0001493152-26-013285.md) | [(0.2)](/filings/0001493152-26-023864.md) | [0.1 d](/filings/0001493152-26-036603.md) | [(0.1) d](/filings/0001493152-25-025230.md) | [(5.3) d](/filings/0001493152-26-013285.md) | [(2.2)](/filings/0001493152-26-023864.md) | [(1.3) d](/filings/0001493152-26-036603.md) |
| Capital expenditure | $m | not reported | [0.0](/filings/0001493152-26-023864.md) | [0.0 d](/filings/0001493152-26-036603.md) | not reported | not reported | [0.0](/filings/0001493152-26-023864.md) | [0.0 d](/filings/0001493152-26-036603.md) |
| Share repurchases | $m | [(36.6) d](/filings/0001493152-26-013285.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.3](/filings/0001493152-26-023864.md) | [7.3](/filings/0001493152-26-036603.md) | [28.9](/filings/0001493152-26-023864.md) | [29.0](/filings/0001493152-26-036603.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,985,302 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036603.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.